Raymond James recently upgraded Baldwin Insurance Group (BWIN) following a period of industry leading organic growth, margin expansion, and stronger adjusted earnings. The company also approved a US$250 million share repurchase program over the next year.
See our latest analysis for Baldwin Insurance Group.
Despite the recent upgrade and buyback announcement, Baldwin Insurance Group’s recent performance has been weak, with a 30 day share price return of 9.21% and a 1 year total shareholder return decline of 53.25%, suggesting sentiment has cooled after earlier optimism.
If you are reassessing your portfolio after Baldwin Insurance Group’s pullback, this can be a good moment to widen your search and check out 20 top founder-led companies
With the stock around US$21.09 and the average analyst price target at US$30.22, the key question for you is simple: is this pullback a potential entry point or is the market already pricing in future growth?
Most Popular Narrative: 33% Undervalued
With Baldwin Insurance Group’s fair value estimate at $31.50 versus a last close of $21.09, the most followed narrative sees a sizable valuation gap, built on a specific view of growth, profitability, and required return at a 7.38% discount rate.
The analysts have a consensus price target of $41.375 for Baldwin Insurance Group based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $52.0, and the most bearish reporting a price target of just $31.0.
Want to see what is sitting behind that valuation gap? The narrative focuses on rapid earnings acceleration, steady revenue compounding, and a relatively high future profit multiple that is more often associated with high growth stories.
Result: Fair Value of $31.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there is still a real risk that pricing pressure in key lines and elevated leverage of around 4.17x could weaken margins and constrain financial flexibility.
Find out about the key risks to this Baldwin Insurance Group narrative.
Another Angle on Valuation
The fair value narrative points to Baldwin Insurance Group trading below an estimated $31.50, but the P/S ratio tells a different story. At 1.4x sales, the stock sits above both the US Insurance industry at 1x and its own fair ratio of 1x. This suggests there may be less room for error if growth or margins disappoint.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment clearly split between risks and rewards, this is a good time to look through the details yourself and act quickly to form your own view by checking the 1 key reward and 2 important warning signs
Looking for more investment ideas?
If Baldwin Insurance Group has you rethinking your next move, do not stop here, broaden your watchlist now so you do not miss other clear opportunities.
- Spot potential bargains early by scanning 62 high quality undervalued stocks and see which companies currently trade below their assessed worth.
- Prioritise resilience by checking 64 resilient stocks with low risk scores to find companies with lower overall risk scores that could help steady your portfolio.
- Add quality to your holdings by reviewing the solid balance sheet and fundamentals stocks screener (39 results) for businesses with stronger financial footing and fundamentals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com